Xuanzhu Biopharmaceutical Signs Thailand Commercial Agreement with Innobic and ZaoAn for Bireociclib
Xuanzhu Biopharmaceutical (HKG: 2575) announced that it has entered into a tripartite commercial agreement with...
Innobic
Mabwell Bioscience Enters Thai Market with Licensing Deal with Innobic
Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062), a Chinese biopharmaceutical company, has announced the signing...